EUVIMEDEUVIMED entdecken
Crossref

Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis

Semra Aytürk Salt

Signa Vitae · 08.08.2026

DOI: 10.22514/sv.2026.041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Signa Vitae, online erschienen am 08.08.2026. Verfasst von Semra Aytürk Salt.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Salt, S. A. (2026). Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis. Signa Vitae. https://doi.org/10.22514/sv.2026.041

Vancouver

Salt SA. Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis. Signa Vitae. 2026. doi:10.22514/sv.2026.041

BibTeX
@article{Salt2026,
  author = {Salt, Semra Aytürk},
  title = {Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis},
  journal = {Signa Vitae},
  year = {2026},
  doi = {10.22514/sv.2026.041}
}
Kostenlos starten →